Resources

A new endoscopic duodenal mucosal resurfacing treatment could lead to T2D patients becoming insulin-free. 

A perspective on the selection of the optimal type 2 diabetes treatment based on precision medicine-based strategies.  

Treatment of diabetes in patients undergoing organ replacement is not often studied.

How physical activity and dietary intervention affect fasting insulin levels and insulin resistance in children. 

How NAFLD screenings can be cost-effective in people with type 2 diabetes. 

Susan received a phone call from her clinician's office recommending that she start using a pen for her insulin. She had also been prescribed a GLP-1 receptor agonist and was to go to the pharmacy to pick them up.
She went and signed up for the long 'discourse' patients receive when they pick up new meds including questions such as whether or not the pharmacist had offered instructions and pages of small print. She, like many of our patients, signed the sheets and went on her own way without ever talking to a pharmacist or asking a question.

Although not the most prevalent comorbid condition in patients with T2DM, heart failure was the most fatal in a 17-year long nationwide real-life cohort study. 

Newly-diagnosed diabetes and admission hyperglycemia are linked to rapid respiratory deterioration in COVID-19 patients. 

Multiple treatments were compared to improve outcomes in patients with prediabetes.

Technology and unique rapid-acting insulin can improve time in range and Quality of Life for patients with diabetes.